cilastatin has been researched along with Cross Infection in 45 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (24.44) | 18.7374 |
| 1990's | 14 (31.11) | 18.2507 |
| 2000's | 13 (28.89) | 29.6817 |
| 2010's | 7 (15.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CH; Lin, CH; Lin, JS | 1 |
| Chang, HL; Chang, HY; Chang, YF; Chi, CY; Ho, CM; Ho, MW; Lai, CH; Lin, CD; Lin, CW; Lin, HH; Lu, JJ; Teng, LJ; Tien, N; Tseng, SP | 1 |
| Hsueh, PR; Lee, YT; Tsao, SM | 1 |
| Piyasirisilp, S; Premprawat, W; Thamlikitkul, V | 1 |
| Chuang, YC; Cooper, CA; Dartois, N; Datsenko, O; Dukart, G; Dzyublik, O; Freire, AT; Gandjini, H; Glumcher, F; Kim, MJ; Korth-Bradley, JM; Maroko, RT; Melnyk, V | 1 |
| Choi, SH; Chung, J; Hong, SB; Jang, HJ; Kim, JW; Koh, Y; Lim, CM | 1 |
| Anderson, DJ; Bennett, KM; Dotson, TL; Sarraf-Yazdi, S; Sharpe, M; Vaslef, SN | 1 |
| Boulanger, BR; Fogarty, C; Fowler, C; Kahn, JB; Morgan, N; Oross, M; Tennenberg, A; West, M; Wiesinger, B; Wu, SC | 1 |
| Alvarez-Lerma, F; Blanco, A; Domínguez-Muñoz, JE; Gener, J; Maraví-Poma, E; Olaechea, P | 1 |
| Aymon, D; Bally, F; Bille, J; Chiolero, R; Cometta, A; Garbino, J; Glauser, MP; Greub, G; Kinge, T; Krawczyk, L; Lew, D; Romand, JA; Rubinstein, E; Schaller, MD; Stratchounski, L; Zanetti, G | 1 |
| Qian, YS; Xiao, GX; Zhuo, C | 1 |
| Brink, AJ; Feldman, C; Grolman, DC; Muckart, D; Pretorius, J; Richards, GA; Senekal, M; Sieling, W | 1 |
| Kollef, MH; Shorr, AF; Susla, GB | 1 |
| Jackson, WL; Kollef, MH; Ramage, AS; Shorr, AF; Tennenberg, AM; Wu, SC; Zadeikis, N | 1 |
| Cooper, A; Joshi, M; Kassira, W; McCarthy, M; Metzler, M; Olvey, S | 1 |
| Bille, J; Bugnon, D; Cotting, J; Décosterd, L; Giannoni, E; Majcherczyk, P; Moessinger, A; Moreillon, P; Zanetti, G | 1 |
| Leitner, E; Lode, H; Schmitt, DV; Welte, T | 1 |
| Bonello, M; Dell'Aquila, R; Loreto, PD; Nalesso, F; Rodighiero, MP; Ronco, C; Spanò, E | 1 |
| Bulitta, JB; Drusano, GL; Glauner, AK; Kinzig-Schippers, M; Pfister, W; Sakka, SG; Sörgel, F | 1 |
| Eller, J; Hamacher, J; Lode, H; Schaberg, T | 1 |
| Finch, RG; Glauser, M; Norrby, SR | 1 |
| de Champs, C; Gazuy, N; Guelon, D; Henquell, C; Sirot, D; Sirot, J | 1 |
| Bastian, A; Bestehorn, K; Büchele, G; Gaus, W; Laubenthal, HJ; Rodloff, AC | 1 |
| Baldassarre, R; Comunale, L; Poletti, G; Tallarigo, C | 1 |
| Cheadle, WG; Fabian, T; Fry, DE; Gardner, SA; Kesterson, L; Livingston, DH; Malangoni, MA; Polk, HC; Trachtenberg, LS | 1 |
| Blanquer, J; Cobo, L; Corcia, S; Daguerre, M; de Latorre, FJ; Del Nogal, F; Garau, J; León, C; Net, A; Rello, J | 1 |
| Adhikari, M; Pillay, DG; Pillay, T; Sturm, AW | 1 |
| Ambrosetti, P; Aymon, D; Bille, J; Chiolero, R; Cometta, A; Glauser, MP; Harbarth, S; Huber, O; Jaccard, C; Lew, D; Praz, G; Ricou, B; Romand, J; Schneider, R; Troillet, N; Zanetti, G | 1 |
| Alvarez-Lerma, F; Bauer, TT; Blanquer, J; Castillo, F; Leal-Noval, SR; León-Gil, C; Martínez-Pellús, A; Nadal, P; Palomar, M; Ros, F; Torres, A | 1 |
| Benedetto, G; Enrichens, F; Franchello, A; Mao, P; Olivero, G; Olivero, S; Sciascia, C | 1 |
| Bengel, D; Przechera, M; Risler, T | 1 |
| Norrby, SR | 1 |
| Asmus, S; Bodmann, KF; Hartenauer, U; Koch, EM; Ritzerfeld, WW; Weilemann, LS | 1 |
| Fujita, J; Higuchi, K; Irino, S; Nakano, M; Negayama, K; Yamaji, Y | 1 |
| Baratta, E; Bucaneve, G; Del Favero, A; Grignani, F; Menichetti, F; Pasticci, MB; Patoia, L | 1 |
| Forder, AA; Linton, DM; Plumb, H; Potgieter, PD | 1 |
| Roselle, GA | 1 |
| Bure, AM; Laisne, MJ; Pangon, B; Regnier, B; Rouveix, E; Vachon, F; Wolff, M | 1 |
| Daikos, GK; Galanakis, N; Giamarellou, H; Sfikakis, P; Voutsinas, D | 1 |
| Bertch, K; Foster, TS; Rapp, RP; Tibbs, P; Young, B | 1 |
| Cumberland, NS; Jones, KP | 1 |
| Forst, H; Lenhart, FP; Ruckdeschel, G; Unertl, K | 1 |
| Duma, RJ; Gebhart, RL; Groschel, DH; Mandell, GL; Palmer, DL; Salata, RA; Scheld, WM; Wade, BH; Wenzel, RP | 1 |
4 review(s) available for cilastatin and Cross Infection
| Article | Year |
|---|---|
Appropriate use of the carbapenems.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cilastatin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Lactams; Meropenem; Patient Selection; Pneumonia, Bacterial; Practice Patterns, Physicians'; Protease Inhibitors; South Africa; Surgical Wound Infection; Thienamycins; Urinary Tract Infections | 2004 |
Quinolones for treatment of nosocomial pneumonia: a meta-analysis.
Topics: Anti-Infective Agents; Cilastatin; Ciprofloxacin; Cross Infection; Humans; Imipenem; Levofloxacin; Meta-Analysis as Topic; Ofloxacin; Pneumonia, Bacterial; Quinolones; Randomized Controlled Trials as Topic | 2005 |
Changing role of carbapenems in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ceftazidime; Cilastatin; Clinical Trials as Topic; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Respiratory Tract Infections; Thienamycins | 1995 |
[Multicenter comparative study of meropenem vs. imipenem in the intramuscular treatment of hospital infections of the urinary tract].
Topics: Adult; Aged; Carbapenems; Chi-Square Distribution; Cilastatin; Cross Infection; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Protease Inhibitors; Thienamycins; Urinary Tract Infections | 1995 |
19 trial(s) available for cilastatin and Cross Infection
| Article | Year |
|---|---|
Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Double-Blind Method; Drug Combinations; Hospital Mortality; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Pneumonia; Pneumonia, Ventilator-Associated; Tigecycline; Treatment Outcome | 2010 |
Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial.
Topics: Aged; Anti-Infective Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Female; Hospital Mortality; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Time Factors; Treatment Outcome; Vancomycin | 2012 |
Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study.
Topics: Adult; Aged; Anti-Bacterial Agents; Cilastatin; Ciprofloxacin; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Prospective Studies; Pseudomonas aeruginosa | 2003 |
Early antibiotic treatment (prophylaxis) of septic complications in severe acute necrotizing pancreatitis: a prospective, randomized, multicenter study comparing two regimens with imipenem-cilastatin.
Topics: Aged; Antibiotic Prophylaxis; APACHE; Cause of Death; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Administration Schedule; Drug Combinations; Female; Hospital Mortality; Humans; Imipenem; Incidence; Infection Control; Male; Middle Aged; Pancreatitis, Acute Necrotizing; Prospective Studies; Sepsis; Severity of Illness Index; Spain; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study.
Topics: Adult; Aged; APACHE; Cefepime; Cephalosporins; Cilastatin; Critical Care; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Endpoint Determination; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia, Pneumococcal; Prospective Studies; Protease Inhibitors; Respiration, Artificial; Thienamycins | 2003 |
Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial.
Topics: Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Cross Infection; Double-Blind Method; Drug Combinations; Drug Resistance, Bacterial; Female; Humans; Imipenem; Levofloxacin; Male; Middle Aged; Multivariate Analysis; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Thienamycins; Treatment Outcome; Ventilators, Mechanical | 2005 |
Comparison of piperacillin/tazobactam and imipenem/cilastatin, both in combination with tobramycin, administered every 6 h for treatment of nosocomial pneumonia.
Topics: Anti-Bacterial Agents; Cilastatin; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Protease Inhibitors; Tazobactam; Tobramycin; Treatment Outcome | 2006 |
Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia--a double blind prospective multicentre study.
Topics: Adult; Cilastatin; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Penicillanic Acid; Piperacillin; Pneumonia; Prospective Studies; Pseudomonas Infections; Tazobactam; Treatment Outcome | 2006 |
Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Cilastatin; Critical Illness; Cross Infection; Drug Combinations; Female; Humans; Imipenem; Infusions, Intravenous; Logistic Models; Male; Middle Aged; Monte Carlo Method; Protease Inhibitors; Tandem Mass Spectrometry; Treatment Outcome | 2007 |
Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. European Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged | 1993 |
[Comparative study of the cost-/effectiveness relationship of initial therapy with imipenem/cilastatin in nosocomial pneumonia. Group study].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cilastatin; Cost-Benefit Analysis; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Protease Inhibitors; Thienamycins; Treatment Outcome | 1996 |
[Multicenter comparative study of meropenem vs. imipenem in the intramuscular treatment of hospital infections of the urinary tract].
Topics: Adult; Aged; Carbapenems; Chi-Square Distribution; Cilastatin; Cross Infection; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Protease Inhibitors; Thienamycins; Urinary Tract Infections | 1995 |
Treatment of pneumonia in mechanically ventilated trauma patients. Results of a prospective trial.
Topics: Aztreonam; Bronchoalveolar Lavage Fluid; Cilastatin; Cross Infection; Drug Therapy, Combination; HLA-DR Antigens; Humans; Imipenem; Pneumonia; Prospective Studies; Respiration, Artificial; Vancomycin; Wounds and Injuries | 1997 |
Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Thienamycins | 1997 |
Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.
Topics: Acute Disease; Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Pneumonia; Prospective Studies; Pseudomonas Infections; Tazobactam | 1998 |
Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin.
Topics: Adult; Aged; Anti-Infective Agents; Cilastatin; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Protease Inhibitors; Survival Rate; Thienamycins; Treatment Outcome | 2000 |
Imipenem-cilastatin in the treatment of hospital infections.
Topics: Cilastatin; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Imipenem; Prognosis; Protease Inhibitors; Thienamycins; Treatment Outcome | 1991 |
Challenges in the design of trials to evaluate antibacterial agents in serious infections.
Topics: Ceftazidime; Cilastatin; Cross Infection; Drug Combinations; Europe; Female; Humans; Imipenem; Male; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Research Design; Urinary Tract Infections | 1990 |
Comparative clinical trial of ceftazidime and imipenem/cilastatin in patients with severe nosocomial pneumonias and septicaemias.
Topics: Ceftazidime; Cilastatin; Cross Infection; Drug Combinations; Female; Germany, West; Humans; Imipenem; Male; Middle Aged; Multicenter Studies as Topic; Pneumonia; Randomized Controlled Trials as Topic; Respiration, Artificial; Sepsis | 1990 |
23 other study(ies) available for cilastatin and Cross Infection
| Article | Year |
|---|---|
Bacteremia caused by Elizabethkingia meningoseptica in a mechanically ventilated patient successfully treated with imipenem-cilastatin and ciprofloxacin.
Topics: Anti-Bacterial Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Flavobacteriaceae Infections; Humans; Imipenem; Male; Middle Aged | 2017 |
Repeated colonization by multi-drug-resistant Acinetobacter calcoaceticus-A. baumannii complex and changes in antimicrobial susceptibilities in surgical intensive care units.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Cefepime; Cephalosporins; Chi-Square Distribution; China; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Care; Cross Infection; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Public Health Surveillance; Retrospective Studies | 2013 |
Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Cilastatin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Minocycline; Piperacillin; Sulbactam; Tigecycline; Treatment Outcome | 2013 |
Therapeutic equivalence of generic imipenem/cilastatin for therapy of infections at Siriraj Hospital.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cross Infection; Drugs, Generic; Female; Hospitalization; Hospitals, University; Humans; Imipenem; Male; Medical Records; Middle Aged; Thailand; Therapeutic Equivalency; Treatment Outcome | 2010 |
A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Care; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Surgical Wound Infection | 2012 |
[Investigation on the antibiotic resistance and risky factors of nosocomial infections caused by Stenotrophomonas maltophilia].
Topics: Antibiosis; Cilastatin; Cross Infection; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Risk Factors; Stenotrophomonas maltophilia | 2004 |
Prospective determination of plasma imipenem concentrations in critically ill children.
Topics: Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Illness; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Infant, Newborn; Infusions, Intravenous; Male | 2006 |
Successful use of sodium hypochlorite pack plus systemic and local antibiotic therapy for the treatment of pseudomonas infection of peritoneal dialysis catheter exit-site.
Topics: Anti-Bacterial Agents; Catheters, Indwelling; Cilastatin; Cross Infection; Disinfectants; Drug Therapy, Combination; Humans; Imipenem; Infection Control; Kidney Failure, Chronic; Peritoneal Dialysis; Peritonitis; Pseudomonas Infections; Sodium Hypochlorite | 2007 |
Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem.
Topics: Bacterial Outer Membrane Proteins; Bacterial Typing Techniques; beta-Lactamases; Cephalosporinase; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 1993 |
Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates.
Topics: Anti-Infective Agents; beta-Lactamase Inhibitors; Cilastatin; Ciprofloxacin; Cross Infection; Drug Combinations; Drug Resistance, Microbial; Drug Resistance, Multiple; Enzyme Inhibitors; Female; Humans; Imipenem; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Protease Inhibitors; Retrospective Studies; Tazobactam; Thienamycins | 1998 |
Pharmacokinetics of imipenem/cilastatin during continuous arteriovenous hemofiltration.
Topics: Acute Kidney Injury; Adult; Aged; Bacterial Infections; Cilastatin; Cross Infection; Drug Therapy, Combination; Female; Half-Life; Hemofiltration; Humans; Imipenem; Male; Metabolic Clearance Rate; Middle Aged | 1991 |
Changes in clinically separated strains of glucose non-fermented gram-negative bacilli following the induction of imipenem/cilastatin.
Topics: Bacterial Infections; Cilastatin; Cross Infection; Fermentation; Glucose; Gram-Negative Bacteria; Humans; Imipenem; Retrospective Studies | 1991 |
Imipenem/cilastatin in the treatment of severe hospital infections.
Topics: Adult; Aged; Amikacin; Cilastatin; Cross Infection; Cyclopropanes; Dipeptidases; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Thienamycins | 1988 |
Imipenem/cilastatin in the treatment of severe nosocomial pneumonia.
Topics: Adolescent; Adult; Aged; Cilastatin; Cross Infection; Dipeptidases; Drug Combinations; Drug Evaluation; Female; Humans; Imipenem; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia | 1988 |
Imipenem-cilastatin. A new dimension.
Topics: Adolescent; Adult; Aged; Cilastatin; Cross Infection; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia | 1988 |
Nosocomial and nursing home-acquired pneumonia. Recent therapeutic advances.
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Cilastatin; Clavulanic Acid; Clavulanic Acids; Cross Infection; Cyclopropanes; Humans; Imipenem; Nursing Homes; Pneumonia; Thienamycins; Ticarcillin | 1987 |
Experience with imipenem/cilastatin in the intensive care unit.
Topics: Adolescent; Adult; Aged; Cilastatin; Critical Care; Cross Infection; Cyclopropanes; Dipeptidases; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Thienamycins | 1986 |
Evaluation of imipenem/cilastatin against nosocomial infections and multiresistant pathogens.
Topics: Adult; Aged; Bacteria; Cilastatin; Cross Infection; Cyclopropanes; Dipeptidases; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Middle Aged; Thienamycins | 1986 |
Clinical outcome of nosocomial pneumonia following imipenem/cilastatin therapy.
Topics: Adult; Cilastatin; Cross Infection; Cyclopropanes; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia; Thienamycins | 1987 |
Hospital acquired native valve endocarditis caused by Acinetobacter calcoaceticus and treated with imipenem/cilastin.
Topics: Acinetobacter Infections; Adult; Aortic Valve; Burns; Cilastatin; Cross Infection; Cyclopropanes; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Imipenem; Male; Military Personnel; Sepsis; Thienamycins; Wound Infection | 1987 |
Imipenem/cilastatin: monotherapy of hospital infections.
Topics: Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Cyclopropanes; Drug Combinations; Humans; Imipenem; Thienamycins | 1987 |
[Treatment of respiratory tract infections with imipenem/cilastatin in critical patients with respiratory insufficiency].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Respiration, Artificial; Respiratory Insufficiency; Respiratory Tract Infections; Thienamycins | 1986 |
Pneumonia treated with imipenem/cilastatin.
Topics: Adult; Aged; Bacteria; Bacterial Infections; Cilastatin; Cross Infection; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia; Pseudomonas Infections; Thienamycins | 1985 |